Dark

Check out our Dark Pool Levels

ADRO
Aduro Biotech, Inc. Common Stock
stock NASDAQ

Inactive

Oct 5, 2020

14.60USD+4.176%(+0.59)171,579

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Oct 15, 2020

05:22PM EDT Versant Venture Capital In 13D Filing Reports 11.2% Stake In Chinook Therapeutics (Formerly ADURO Biotech) Benzinga

Oct 5, 2020

09:00AM EDT Combined Company Will HaveOver $275 Million in Operating Capital and Trade on Nasdaq under the Ticker Symbol KDNY GlobeNewswire Inc

Oct 2, 2020

11:20AM EDT Shares of Aduro Biotech, Inc. (ADRO) are gaining over 8% on Friday morning after the clinical-stage biopharmaceutical company's stockholders approved a merger deal with Chinook Therapeutics. RTTNews

Oct 1, 2020

04:07PM EDT Aduro Biotech Also Announced A One-For-Five Reverse Stock Split To Be Effective October 2, 2020 Benzinga

04:06PM EDT Aduro Biotech Stockholders Approve A Merger Agreement With Chinook Therapeutics Benzinga

04:05PM EDT Aduro Biotech Stockholders Approve Merger Agreement with Chinook GlobeNewswire Inc

Aug 18, 2020

08:19AM EDT Chinook Therapeutics Announces $106M Private Placement Financing To Advance Precision Medicines For Kidney Disease Benzinga

Aug 3, 2020

04:26PM EDT Aduro Biotech Q2 EPS $(0.21) Up From $(0.23) YoY, Sales $5.57M Up From $4.89M YoY Benzinga

04:06PM EDT Aduro Biotech Provides Business Update and Reports Second Quarter GlobeNewswire Inc

Share